About the ABPI

The ABPI represents innovative resea​rch-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.

Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.

Globally our industry is researching and developing more than 7,000 new medicines.

The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK.​​​​​​​

About ABPI Vaccine Group

The ABPI Vaccine Group is committed to advocating on behalf of the industry on all aspects of vaccination and the benefits it brings to the health of our nation.  The Group aims to work in partnership with the public health community throughout the four nations of the UK to encourage the continued and further success of the national immunisation programmes.

Westminster Flu Day is supported by the following companies:

  • AstraZeneca
  • GlaxoSmithKline
  • Mylan
  • Novartis Influenza Vaccines
  • Takeda

Notes to Editors

Current Flu Vaccination Policy in England.4

According to the influenza immunisation programme 2015/16, an influenza vaccination should be offered for free to:

  1. All those aged 65 and over
  2. All those aged over 6 months in the following clinical 'at-risk' groups:
  • Chronic respiratory disease such as severe asthma, chronic obstructive pulmonary disease (COPD) or bronchitis
  • Chronic heart disease, such as heart failure
  • Chronic kidney disease at stage three, four or five
  • Chronic liver disease
  • Chronic neurological disease such as Parkinson's Disease, Motor Neurone Disease or learning disability
  • Diabetes
  • a weakened immune system due to disease (such as HIV/AIDS) or treatment (such as cancer treatment)
  • splenic dysfunction
  1. Pregnant women
  2. Those living in long-stay residential and nursing homes or other long-stay facilities
  3. Carers who are in receipt of Carers Allowance or those who are the main carer of an elderly or disabled person whose welfare may be at risk if the carer falls ill.
  4. Health and social care workers in the NHS.
  5. All children aged 2,3 and 4.
  6. Consideration should also be given to the vaccination of household contacts of immunocompromised individuals
  7. The Government has also advised that morbidly obese people (defined as BMI 40+) could also benefit from a flu vaccination.

 

References

  1. Public Health England, Surveillance of Influenza and other respiratory viruses in the UK: Winter 2014-2015 p12 and p14 http://bit.ly/1PfGjPK
  2. PHE Flu Letter 2015/16 p3 http://bit.ly/1GcQqSI
  3. PHE Flu Letter 2015/16 p7 http://bit.ly/1GcQqSI
  4. PHE Flu Letter 2015/16 p7 http://bit.ly/1GcQqSI

Media enquiries


+44 (0) 20 7747 7147​​